Keywords (click to sort) | Title | Description | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
['Press release', 'Media release'] | C.E. Info Systems Ltd - 543425 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | Submission of Press Release for Q4 & FY23 Results: MapmyIndia declares FY23 results, Revenue up 41% to Rs 282 Cr, PAT up 24% YoY to Rs 108 Cr and EBITDA margins at 42% | ||||||||||||
['Buyback'] | WIPRO LTD. - 507685 - Update on board meeting | WIPRO LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2023 ,inter alia, to consider and approve The Board of Directors of the Company will be considering a proposal to buyback equity shares of the Company and the matters necessary and incidental thereto, in accordance with the applicable provisions of the Companies Act, 2013 (including the rules and regulations framed thereunder), the Securities .... | ||||||||||||
['Expansion', 'Capacity expansion'] | SHREE DIGVIJAY CEMENT CO.LTD.-$ - 502180 - Environmental Clearance (EC) For Capacity Expansion Of Existing Manufacturing Facilities | The Company has received Environmental Clearance (EC) from the Ministry of Environment ,forest and Climate Change for capacity expansion of existing facilities. | ||||||||||||
['FDA', 'Inspection', 'Update, AND, facility'] | SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Update On Mohali Facility | This is with respect to our prior communications, dated November 8, 2022 and August 13, 2022, regarding the US FDA inspection at the Company's Mohali (Punjab) facility from August 3 to August 12, 2022. As stated earlier, US FDA had classified the inspection as 'Official Action Indicated' (OAI). We now wish to inform you that the Company has received a letter titled 'CONSENT DECREE CORRESPONDENCE/NON-COMPLIANCE LETTER' from the US FDA. US FDA has .... |
Keywords | Title | Description |
---|
Company Name | Purpose | Ex Date |
---|---|---|
JINDAL STAINLESS LTD. - 532508 | Special Dividend - Rs. - 1.0000 | 28 Apr 2023 |
Sanofi India Ltd - 500674 | Special Dividend - Rs. - 183.0000 | 28 Apr 2023 |